HPV vaccineThe objective of this study was to assess the level of knowledge of cervical cancer among Bangladeshi women and to assess their willingness to receive the human papillomavirus (HPV) vaccine. A population-based, cross-sectional survey was conducted from July to December 2011 in one ...
Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study. BMC Womens Health. 2018;18(1):15. Article PubMed PubMed Central Google Scholar Mengesha MB, Chekole TT, Hidru HD. Uptake and barriers to cervical cancer screening among human ...
® and Walrinvax® [25]. AnE. coli-produced 9-valent vaccine is also under development in China by the manufacturer of Cecolin®. This vaccine has been reported to be non-inferior to Gardasil®9 in a head-to-head comparative immunogenicity study involving women aged 18–26 years in ...
implementation of the vaccination programme their focus was on acceptability (intention to accept the vaccine) rather than uptake, but the findings have helped to establish an understanding of the socio-demographic and psychosocial factors, which may have a role in the decision to accept HPV ...
4. Munoz, N., et al., Chapter 1: HPV in the etiology of human cancer. Vaccine, 2006. 24 Suppl 3: p. S3/1-10. 5. Smith, J.S., et al., Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 2007...
Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh. Int J Technol Assess Health Care. 2008;24(4):481–7. https:// doi.org/10.1017/S026646230808063X. 21. Zhou L, Gu B, Xu X, Li Y, ...
HPV vaccine underutilization HPV vaccination is safe and effective.[5,39-45]Over a 9-year period (2004-2013) in the United States, the rate of genital warts decreased by 2% in low-income minority girls and 0.7% in their male counterparts[39]; even more dramatically, within 6 years of HP...
Vaccine. 2008;26:K42–52. 46. Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, et al. Which high-risk HPV assays fulfil criteria for use in primary Cervical cancer screening? Clin Microbiol Infect. 2015;21(9):817–26. 47. Shen S, Zhang S, Liu P, Wang ...
An HPV vaccine is a preventive measure administered in a three-dose series to adolescents aged 11 through 12 years, with the option of using HPV4 or HPV2 for girls and only HPV4 for boys. It is recommended to start vaccination at age 9 to ensure completion before immunosuppression, especial...
Barriers to and facilitators of HPV vaccine uptake among adolescent girls Marlow et atl.,27 2009, UK A qualitative study conducted at participants' home or workplace a. Caribbean and African (n = 10)b. Asian Indian, Asian Pakistani, Asian Bangladeshi, and Asian other (n = ...